Literature DB >> 9639663

The role of neuronal growth factors in neurodegenerative disorders of the human brain.

B Connor1, M Dragunow.   

Abstract

Recent evidence suggests that neurotrophic factors that promote the survival or differentiation of developing neurons may also protect mature neurons from neuronal atrophy in the degenerating human brain. Furthermore, it has been proposed that the pathogenesis of human neurodegenerative disorders may be due to an alteration in neurotrophic factor and/or trk receptor levels. The use of neurotrophic factors as therapeutic agents is a novel approach aimed at restoring and maintaining neuronal function in the central nervous system (CNS). Research is currently being undertaken to determine potential mechanisms to deliver neurotrophic factors to selectively vulnerable regions of the CNS. However, while there is widespread interest in the use of neurotrophic factors to prevent and/or reduce the neuronal cell loss and atrophy observed in neurodegenerative disorders, little research has been performed examining the expression and functional role of these factors in the normal and diseased human brain. This review will discuss recent studies and examine the role members of the nerve growth factor family (NGF, BDNF and NT-3) and trk receptors as well as additional growth factors (GDNF, TGF-alpha and IGF-I) may play in neurodegenerative disorders of the human brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639663     DOI: 10.1016/s0165-0173(98)00004-6

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  104 in total

Review 1.  Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1.

Authors:  S A Loddick; N J Rothwell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Progressive transneuronal changes in the brainstem and thalamus after long-term dorsal rhizotomies in adult macaque monkeys.

Authors:  T M Woods; C G Cusick; T P Pons; E Taub; E G Jones
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

3.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

4.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

5.  Caloric restriction improves memory in elderly humans.

Authors:  A V Witte; M Fobker; R Gellner; S Knecht; A Flöel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

6.  Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.

Authors:  Ashley J Szabo; Michael L Alosco; Lindsay A Miller; John E McGeary; Athena Poppas; Ronald A Cohen; John Gunstad
Journal:  Psychogeriatrics       Date:  2013-10-28       Impact factor: 2.440

7.  Expression of nerve growth factor and brain-derived neurotrophic factor in astrocytomas.

Authors:  Ting-Ting Liu; Hao Wang; Feng Juan Wang; Yu Feng Xi; Li Hua Chen
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

8.  Regulation of brain-derived neurotrophic factor expression in neurons.

Authors:  Fei Zheng; Xianju Zhou; Changjong Moon; Hongbing Wang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

Review 9.  Neurotrophic factors for the investigation and treatment of movement disorders.

Authors:  Justo Garcia De Yébenes; Marina Sánchez; Maria Angeles Mena
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells.

Authors:  Jie Bai; Hajime Nakamura; Yong-Won Kwon; Itaro Hattori; Yoshimi Yamaguchi; Yong-Chul Kim; Norihiko Kondo; Shin-ichi Oka; Shugo Ueda; Hiroshi Masutani; Junji Yodoi
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.